Trane Technologies (NYSE: TT) CEO awarded RSUs and 31,111-share option

Rhea-AI Filing Summary

Trane Technologies plc’s Chair and CEO David S. Regnery reported equity awards dated February 3, 2026. He received 8,327 restricted stock units representing ordinary shares at no cost, vesting in three equal annual installments beginning on February 3, 2027.

He was also granted a stock option for 31,111 ordinary shares at an exercise price of $435.36, vesting in three pro rata annual installments starting February 3, 2027 and expiring February 2, 2036. Following these awards, he directly beneficially owns 107,542.12 ordinary shares, and 24,500 additional shares are held indirectly by a revocable trust established by his spouse.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regnery David S

(Last) (First) (Middle)

C/O TRANE TECHNOLOGIES COMPANY LLC

800-E BEATY STREET

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trane Technologies plc [ TT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/03/2026		A		8,327(1)	A	$0	107,542.12	D
Ordinary Shares (Trust)								24,500(2)	I	By Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$435.36	02/03/2026		A		31,111		(3)	02/02/2036	Ordinary Shares	31,111	$0	31,111	D

Explanation of Responses:

1. Represents restricted stock units that vest in three (3) equal annual installments beginning on February 3, 2027.

2. Shares held by a revocable trust established by the reporting person's spouse, of which trust the reporting person's spouse is the sole trustee and sole beneficiary.

3. The stock option vests in three (3) pro rata annual installments beginning on February 3, 2027.

Remarks:

	/s/ Eric R. Waller, Attorney-in-Fact	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Trane Technologies (TT) disclose in this Form 4 filing?

Trane Technologies disclosed new equity awards to Chair and CEO David S. Regnery. He received restricted stock units and stock options in ordinary shares as part of his compensation, with multi‑year vesting schedules beginning February 3, 2027, and an option expiration in 2036.

How many restricted stock units did Trane CEO David Regnery receive?

David Regnery received 8,327 restricted stock units representing ordinary shares at a grant price of $0. These units vest in three equal annual installments starting February 3, 2027, meaning one‑third of the award becomes payable in shares each year over three years.

What are the terms of the new stock options reported for Trane (TT)?

The filing reports a stock option for 31,111 ordinary shares with an exercise price of $435.36. The option vests in three pro rata annual installments beginning February 3, 2027, and expires on February 2, 2036, providing a long‑dated incentive tied to Trane’s share price.

How many Trane Technologies shares does David Regnery now own directly?

After the reported transactions, David Regnery directly beneficially owns 107,542.12 ordinary shares of Trane Technologies. This figure reflects his direct holdings following the grant of 8,327 restricted stock units, which are subject to vesting beginning in February 2027.

What Trane Technologies shares are held through a trust related to the CEO?

An additional 24,500 ordinary shares are held indirectly through a revocable trust established by David Regnery’s spouse. According to the filing, the spouse is the trust’s sole trustee and sole beneficiary, so these shares are reported as indirectly beneficially owned by the CEO.

Are the Trane (TT) equity awards to the CEO purchases or compensation grants?

The Form 4 shows the equity as compensation grants rather than open‑market purchases. Both the 8,327 restricted stock units and the 31,111 stock options were reported with a transaction code "A" and a price of $0, indicating awards granted as part of his compensation.